Participating in Key Investor Conferences
Journey Medical Corporation, commonly referred to as Journey Medical, is preparing for an exciting month of October 2025, where it will actively participate in notable investor conferences. This engagement presents a valuable opportunity for investors to meet the company’s management team, gaining insights into its future prospects and growth strategy.
Details of the Upcoming Conference Events
Two key events are scheduled for October, showcasing the company's ongoing commitment to transparency and investor relations. The first event is the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025. This event will occur in New York City and offers the format of one-on-one meetings, emphasizing personalized interactions with potential investors.
The second event, scheduled for October 30, 2025, is the ThinkEquity Conference. This conference will feature presentations and further one-on-one meetings, allowing Journey Medical to convey its message to a broader audience while also connecting on a more personal level with investors. These gatherings are crucial as they allow the company to share its vision for the future and discuss strategic initiatives that align with its market goals.
About Journey Medical Corporation
Journey Medical Corporation (NASDAQ: DERM) positions itself as a commercial-stage pharmaceutical company focused on delivering innovative treatment options for dermatological conditions. With a product portfolio that includes eight branded FDA-approved prescription drugs, Journey Medical remains committed to addressing common skin issues effectively.
The company prides itself on an efficient sales and marketing model that promotes its prescription pharmaceutical products. Comprising industry veterans and experts, the Journey Medical team boasts extensive experience in developing and commercializing various successful dermatology brands. This expertise is essential as the company continues to adapt and respond to market needs within dermatological care.
Strategic Background and Company Genesis
Founded by Fortress Biotech, Inc. (NASDAQ: FBIO), Journey Medical has established its headquarters in Scottsdale, Arizona. The company's history signifies a commitment to professional excellence and innovative healthcare solutions. Since its establishment, Journey Medical has focused on maintaining the highest standards of service and quality in every product, fostering trust and reliability within the healthcare community.
Contact Information for Journey Medical
For investors and media inquiries, Journey Medical Corporation provides direct contact details. Jaclyn Jaffe represents the Investor Relations side, reachable at (781) 652-4500, with her email as ir@jmcderm.com. Additionally, for media-related queries, Tony Plohoros from 6 Degrees is available at (908) 591-2839, or via email at tplohoros@6degreespr.com.
Frequently Asked Questions
What is the focus of Journey Medical Corporation?
Journey Medical Corporation focuses on developing and marketing FDA-approved prescription products primarily for dermatological conditions.
When are the upcoming investor conferences for Journey Medical?
The upcoming investor conferences are scheduled for October 9 and October 30, 2025.
What does Journey Medical aim to achieve at these conferences?
Journey Medical aims to provide insights into its operations and growth strategy while building relationships with potential investors.
Who can I contact for more information about Journey Medical's investor relations?
For investor relations inquiries, you can contact Jaclyn Jaffe at (781) 652-4500 or email ir@jmcderm.com.
What is the relationship between Journey Medical and Fortress Biotech?
Journey Medical Corporation was founded by Fortress Biotech, Inc., which supports its operational and strategic endeavors in the pharmaceutical industry.
